Research Activities

The Glycobiology Institute, directed by Prof. Raymond Dwek, has focused its research activities on understanding the biological roles of protein and lipid glycosylation. The use of sugar analogues (imino sugars) to inhibit the biosynthesis and catabolism of glycoconjugates is being exploited by Terry Butters.

Chemistry and biology of imino sugar inhibitors

The use of small molecule inhibitors to enzymes involved in glycoconjugate metabolism is being explored in a number of therapeutic applications. Most of the projects aim to understand the biochemical mechanism for action of inhibitors  in a cellular environment.   These projects are expected to:

i) contribute to the design of improved therapeutics
ii) dissect the pathways of glycoconjugate metabolism in cells and in vivo


Imino Sugars

The discovery that monosaccharide analogues (imino sugars) that contain a nitrogen in the ring instead of oxygen, are potent inhibitors of glycosidases has led to important developments in biochemistry. These include affinity purification of glycosidases, site directed analysis of catalytic mechanisms, and as tools for probing the biosynthesis and function of protein glycoconjugates . The glucose analogues, castanospermine and deoxynojirimycin have found important applications in controlling certain virus infections and diabetes.

Comparison of the structural features of glucose and N-butyl-deoxynojirimycin:

The most exciting discovery that glucose (and galactose) imino sugars have inhibitory activity against the UDP-glucose:ceramide glucosyltransferase allows manipulation of the glycolipid biosynthetic pathway. This has an important therapeutic application in the treatment of inherited metabolic storage disorders such as Gaucher and Tay-Sachs disease, where the catabolism of lipids is impaired. Transferase inhibition, using imino sugars, reduces the levels of cellular glycolipid and thus reduces the burden of stored metabolites. This strategy for the treatment of glycolipid based storage disorders has been termed substrate deprivation and may provide a useful adjunct to enzyme replacement therapy in certain disease states.

Useful links to inherited disorders are also available to the Gaucher Association and to Rare Genetic Diseases in Children